Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis

Helicobacter

Volumn 12, Issue 2, 2007, Pages 124-131

  Hofner, Peter ^a   Gyulai, Zsofia ^a   Kiss, Zsuzsanna F ^a   Tiszai, Andrea ^a   Tiszlavicz, László ^a   Tóth, Gábor ^a   Szõke, Dominika ^b   Molnár, Béla ^b   Lonovics, János ^a   Tulassay, Zsolt ^b   Mándi, Yvette ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Duodenal ulcer; Gastritis; Helicobacter pylori; IL 8; NODI; SNP; TLR4

Indexed keywords

INTERLEUKIN 8; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM DISEASE; DUODENUM ULCER; GASTRITIS; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MELTING POINT; PRIORITY JOURNAL; SERODIAGNOSIS; STOMACH DISEASE;

CASE-CONTROL STUDIES; DUODENAL ULCER; GASTRITIS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; NOD1 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

HELICOBACTER PYLORI;

EID: 33847063192     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00481.x     Document Type: Article

References (34)

1. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004;113:321-33.
2. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 2005;21:653-9.
3. Nedrud JG, Blanchard SS, Czinn SJ. Helicobacter pylori inflammation and immunity. Helicobacter 2002;7:24-9.
4. Mori N, Krensky AM, Geleziunas R, et al. Helicobacter pylori induces RANTES through activation of NF-κB. Infect Immun 2003;71:3748-56.
5. Kudo T, Lu H, Wu JY, Graham H, Casola A, Yamaoka Y. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun 2005;73:7602-12.
6. Nozawa Y, Nishihara K, Peek M Jr, et al. Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem Pharmacol 2002;64:21-30.
7. Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immunol 2004;5:1166-74.
8. Bourzac KM, Guillemin K. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol 2005;7:911-9.
9. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Rev 2006;6:9-20.
10. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2001;3:371-82.
11. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
12. Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr Opin Microbiol 2004;7:25-32.
13. Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 2006;22:95-101.
14. Kim JG, Lee SJ, Kagnoff MF. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect Immun 2004;72:1487-95.
15. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 2005;42:879-85.
16. Backhed F, Rokbi B, Torstensson E, et al. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infect Dis 2003;187:829-36.
17. Schmausser B, Andrulis M, Endrich S, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004;136:521-6.
18. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005;295:179-85.
19. Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003;198:1225-35.
20. Matsumoto J, Yang K, Varambally S, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006;203:203-13.
21. Covacci A, Rappouli R. Tyrosine-phosphorylated bacterial proteins. Trojan horses for the host cell. J Exp Med 2000;191:587-92.
22. Brandt S, Kwok T, Hartig R, König W, Backert S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005;102:9300-5.
23. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-7.
24. Zouali H, Lesage S, Merlin F, et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 2003;52:71-4.
25. Hamann L, Hamprecht A, Gomma A, Schumann RR. Rapid and inexpensive real-time PCR genotyping functional polymorphisms within the Toll-like receptor-2-4, and -9 genes. J Immunol Meth 2004;285:281-91.
26. Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002;166:1449-56.
27. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
28. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002;162:1028-32.
29. Si Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997;113:551-5.
30. Weidinger S, Klopp N, Rummler L, et al. Association of NOD1 polymorphisms with atopic eczema and related phenothypes. J Allergy Clin Immunol 2005;116:177-84.
31. Hysi P, Kabesch M, Moffatt MF, et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005;14:935-41.
32. McGovern DPB, Hysi P, Ahmad T, et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005;14:1245-50.
33. Rosenstiel P, Hellmig S, Hampe J, et al. Influence of polymorphisms in the NOD1/CRD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 2006;8:1188-98.
34. Gyulai Z, Klausz G, Tiszai A, Tóth Kása I, Lonovics J, Mándi Y. Genetic polymorphism of interleukin 8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw 2004;15:353-8.